A randomized, double-blind, multiple-dose escalation study of a Chinese herbal medicine preparation (Dang Gui Buxue Tang) for moderate to severe menopausal symptoms and quality of life in postmenopausal women
- PMID: 22990757
- DOI: 10.1097/gme.0b013e318267f64e
A randomized, double-blind, multiple-dose escalation study of a Chinese herbal medicine preparation (Dang Gui Buxue Tang) for moderate to severe menopausal symptoms and quality of life in postmenopausal women
Abstract
Objective: This study is a phase II clinical trial that aims to investigate the dose-response relationship of a Chinese herbal medicine preparation, Dang Gui Buxue Tang (DBT), with short-term menopausal symptoms and quality of life in local postmenopausal women.
Methods: A randomized, double-blind, multiple-dose escalation trial was performed in 60 postmenopausal women experiencing severe hot flashes and night sweats. The participants were randomized to receive DBT preparations at 1.5, 3.0, or 6.0 g/day for 12 weeks. The primary outcomes were vasomotor symptoms, Greene Climacteric Scale (GCS) score, and Menopause-Specific Quality of Life (MENQOL) score. Secondary outcomes included serum hormones and lipids.
Results: There were between-group differences in psychological/psychosocial (P = 0.015, GCS; P = 0.013, MENQOL) and somatic/physical (P = 0.019, GCS; P = 0.037, MENQOL) domains, and improvement was significantly greatest (P < 0.05) in the 6.0 g/day dose group. The frequency and severity of hot flashes and night sweats were significantly reduced in the 3.0 g/day (14.5%-21.2%, P < 0.05, hot flashes; 28.6%-39.6%, P < 0.05, night sweats) and 6.0 g/day (34.9%-37.4.0%, P < 0.01, hot flashes; 10.1%-12.8%, P < 0.01, night sweats) dose groups. The female hormones follicle-stimulating hormone, luteinizing hormone, and 17β-estradiol, as well as the lipids total cholesterol, triglycerides, low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol, were not significantly different within groups and between groups.
Conclusions: DBT preparations at 6.0 g/day significantly improve physical and psychological scores and significantly reduce vasomotor symptoms from baseline. The treatment was well tolerated, with no serious adverse events noted during the 12-week intervention period. The changes do not affect hormones and lipid profiles.
Similar articles
-
A randomized, double-blind, placebo-controlled study of the effect of a Chinese herbal medicine preparation (Dang Gui Buxue Tang) on menopausal symptoms in Hong Kong Chinese women.Climacteric. 2008 Jun;11(3):244-51. doi: 10.1080/13697130802073029. Climacteric. 2008. PMID: 18568789 Clinical Trial.
-
Soy germ isoflavones improve menopausal symptoms but have no effect on blood lipids in early postmenopausal Chinese women: a randomized placebo-controlled trial.Menopause. 2012 Jul;19(7):791-8. doi: 10.1097/gme.0b013e31823dbeda. Menopause. 2012. PMID: 22278344 Clinical Trial.
-
A randomized, double-blind, controlled trial of a Chinese herbal formula (Er-Xian decoction) for menopausal symptoms in Hong Kong perimenopausal women.Menopause. 2013 Jul;20(7):767-76. doi: 10.1097/GME.0b013e31827cd3dd. Menopause. 2013. PMID: 23793167 Clinical Trial.
-
MF-101, an estrogen receptor beta agonist for the treatment of vasomotor symptoms in peri- and postmenopausal women.Curr Opin Investig Drugs. 2009 Apr;10(4):365-71. Curr Opin Investig Drugs. 2009. PMID: 19337958 Review.
-
Efficacy and safety of fezolinetant for vasomotor symptoms in postmenopausal women: A systematic review and meta-analysis of randomized controlled trials.Int J Gynaecol Obstet. 2024 Sep;166(3):969-983. doi: 10.1002/ijgo.15467. Epub 2024 Apr 2. Int J Gynaecol Obstet. 2024. PMID: 38563867
Cited by
-
Danggui Buxue Tang Ameliorates Bleomycin-Induced Pulmonary Fibrosis by Suppressing the TLR4/NLRP3 Signaling Pathway in Rats.Evid Based Complement Alternat Med. 2021 Jul 23;2021:8030143. doi: 10.1155/2021/8030143. eCollection 2021. Evid Based Complement Alternat Med. 2021. PMID: 34349830 Free PMC article.
-
Exploring the immunometabolic potential of Danggui Buxue Decoction for the treatment of IBD-related colorectal cancer.Chin Med. 2024 Aug 29;19(1):117. doi: 10.1186/s13020-024-00978-y. Chin Med. 2024. PMID: 39210410 Free PMC article. Review.
-
Repressed Exercise-Induced Hepcidin Levels after Danggui Buxue Tang Supplementation in Male Recreational Runners.Nutrients. 2018 Sep 18;10(9):1318. doi: 10.3390/nu10091318. Nutrients. 2018. PMID: 30231484 Free PMC article. Clinical Trial.
-
Chinese herbal medicine for menopausal symptoms.Cochrane Database Syst Rev. 2016 Mar 15;3(3):CD009023. doi: 10.1002/14651858.CD009023.pub2. Cochrane Database Syst Rev. 2016. PMID: 26976671 Free PMC article.
-
Danggui buxue tang inhibits 2,4-dinitrochlorobenzene: induced atopic dermatitis in mice.Evid Based Complement Alternat Med. 2015;2015:672891. doi: 10.1155/2015/672891. Epub 2015 Mar 10. Evid Based Complement Alternat Med. 2015. PMID: 25861366 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources